Bristol-Myers Squibb Co (NYSE:BMY)
$ 44.94 0.2 (0.45%) Market Cap: 91.10 Bil Enterprise Value: 138.84 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 82/100

Q3 2021 Bristol-Myers Squibb Co Earnings Call Transcript

Oct 27, 2021 / 02:00PM GMT
Release Date Price: $56.49 (-3.00%)
Operator

Good day, and welcome to the Bristol-Myers Squibb 2021 Third Quarter Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Tim Power, Vice President, Investor Relations. Please go ahead, sir.

Timothy Power
Bristol-Myers Squibb Company - VP & Head of IR

Thanks, Christina, and good morning, everyone. Thanks for joining us for our third quarter 2021 earnings call. Joining me this morning with prepared remarks are Giovanni Caforio, our Board Chair and Chief Executive Officer; and David Elkins, our Chief Financial Officer. Also, with me for today's call are Chris Boerner, our Chief Commercialization Officer; and Samit Hirawat, our Chief Medical Officer and Head of Global Drug Development.

You'll note that we posted slides to bms.com and you can use those to follow along with David and Giovanni's remarks. But before we get started, I'll read our forward-looking statements. During today's call, we'll make statements about the company's future plans and prospects that constitute

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot